SLC3A2, an integrin-associated protein, was shown to be up-regulated in osteosarcoma samples and cell lines, and its expression was linked to tumor size and stage in osteosarcoma (Zhu et al., 2017). The gene discussed is SLC3A2; the disease is osteosarcoma.